TARO logo

TARO Current Assets

TARO Annual Current Assets

$1.30 B
-$33.02 M-2.47%

31 March 2024

TARO Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Quarterly Current Assets

$1.30 B
-$44.00 M-3.27%

31 March 2024

TARO Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.5%-3.3%
3 y3 years-11.4%-11.4%
5 y5 years-12.1%-10.6%

TARO Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-34.8%-34.8%

Taro Pharmaceutical Industries Current Assets History

DateAnnualQuarterly
Mar 2024
$858.67 M(+7.5%)
$1.30 B(-3.3%)
Dec 2023
-
$1.35 B(+0.4%)
Sept 2023
-
$1.34 B(+3.7%)
June 2023
-
$1.29 B(-3.2%)
Mar 2023
$799.09 M(-4.7%)
$1.34 B(-1.5%)
Sept 2022
-
$1.36 B(+0.6%)
June 2022
-
$1.35 B(+0.8%)
Mar 2022
$838.48 M(-10.4%)
$1.34 B(+8.1%)
Dec 2021
-
$1.24 B(-12.4%)
Sept 2021
-
$1.41 B(-4.6%)
June 2021
-
$1.48 B(+0.7%)
Mar 2021
$936.04 M(+15.8%)
$1.47 B(-3.4%)
Dec 2020
-
$1.52 B(+2.5%)
Sept 2020
-
$1.49 B(-2.4%)
June 2020
-
$1.52 B(-0.6%)
Mar 2020
$808.65 M(+23.9%)
$1.53 B(+5.1%)
Dec 2019
-
$1.46 B(-1.5%)
Sept 2019
-
$1.48 B(-3.5%)
June 2019
-
$1.53 B(+3.4%)
Mar 2019
$652.61 M(+21.6%)
$1.48 B(+1.4%)
Dec 2018
-
$1.46 B(-21.6%)
Sept 2018
-
$1.87 B(+1.7%)
June 2018
-
$1.83 B(-3.3%)
Mar 2018
$536.58 M(+84.6%)
$1.90 B(-0.5%)
Dec 2017
-
$1.91 B(-1.0%)
Sept 2017
-
$1.93 B(-0.4%)
June 2017
-
$1.93 B(-3.2%)
Mar 2017
$290.73 M(-6.3%)
$2.00 B(+12.2%)
Dec 2016
-
$1.78 B(+12.8%)
Sept 2016
-
$1.58 B(-6.3%)
June 2016
-
$1.69 B(-10.3%)
Mar 2016
$310.44 M(+38.6%)
$1.88 B(+0.7%)
Dec 2015
-
$1.87 B(+9.2%)
Sept 2015
-
$1.71 B(+8.8%)
June 2015
-
$1.57 B(+3.8%)
Mar 2015
$223.94 M(-3.9%)
$1.51 B(+12.0%)
Dec 2014
-
$1.35 B(+11.3%)
Sept 2014
-
$1.21 B(+11.0%)
June 2014
-
$1.09 B(+4.1%)
Mar 2014
$233.10 M(+18.4%)
$1.05 B(+7.5%)
Dec 2013
-
$978.37 M(-10.8%)
Sept 2013
-
$1.10 B(+12.4%)
June 2013
-
$975.57 M(+7.2%)
Mar 2013
$196.87 M(-2.9%)
$909.77 M(+8.1%)
Dec 2012
-
$841.67 M(+9.2%)
Sept 2012
-
$770.82 M(+13.6%)
June 2012
-
$678.72 M(+3.8%)
Mar 2012
$202.76 M(-5.4%)
$653.66 M(+12.4%)
Dec 2011
$214.41 M(-17.8%)
$581.43 M(+19.1%)
Sept 2011
-
$488.23 M(+23.4%)
June 2011
-
$395.51 M(+14.7%)
Mar 2011
-
$344.73 M(+16.6%)
Dec 2010
$260.81 M(-8.9%)
$295.64 M(-6.0%)
Sept 2010
-
$314.56 M(+6.9%)
June 2010
-
$294.33 M(+1.7%)
Dec 2009
$286.38 M
$289.50 M(+3.0%)
Sept 2009
-
$280.96 M(+15.0%)
June 2009
-
$244.36 M(+5.0%)
DateAnnualQuarterly
Mar 2009
-
$232.62 M(+2.6%)
Dec 2008
$246.47 M(-10.4%)
$226.63 M(-7.3%)
Sept 2008
-
$244.56 M(+23.8%)
Dec 2007
$274.93 M(-5.6%)
-
Dec 2006
$291.29 M(-16.9%)
-
Dec 2005
$350.69 M(-3.6%)
$197.52 M(-38.8%)
Sept 2005
-
$322.76 M(+0.1%)
June 2005
-
$322.59 M(+3.5%)
Mar 2005
-
$311.81 M(-6.4%)
Dec 2004
$363.73 M(+56.2%)
$333.11 M(+6.7%)
Sept 2004
-
$312.18 M(-7.4%)
June 2004
-
$337.13 M(-7.1%)
Mar 2004
-
$363.06 M(-5.4%)
Dec 2003
$232.83 M(+89.7%)
$383.69 M(+16.9%)
Sept 2003
-
$328.23 M(+6.1%)
June 2003
-
$309.48 M(+19.9%)
Mar 2003
-
$258.04 M(+0.4%)
Dec 2002
$122.73 M(+60.9%)
$257.12 M(+7.4%)
Sept 2002
-
$239.39 M(-1.5%)
June 2002
-
$242.98 M(+3.3%)
Mar 2002
-
$235.30 M(+1.6%)
Dec 2001
$76.27 M(+56.6%)
$231.49 M(+146.2%)
Sept 2001
-
$94.02 M(+8.3%)
June 2001
-
$86.83 M(+20.4%)
Mar 2001
-
$72.12 M(+0.5%)
Dec 2000
$48.71 M(+21.1%)
$71.74 M(+1.1%)
Sept 2000
-
$70.97 M(+26.1%)
June 2000
-
$56.26 M(+4.2%)
Mar 2000
-
$53.98 M(+6.4%)
Dec 1999
$40.23 M(+15.4%)
$50.73 M(-1.5%)
Sept 1999
-
$51.50 M(+8.4%)
June 1999
-
$47.50 M(+17.3%)
Mar 1999
-
$40.50 M(+2.0%)
Dec 1998
$34.87 M(+2.2%)
$39.70 M(-5.5%)
Mar 1998
-
$42.00 M(+11.7%)
Dec 1997
$34.10 M(+18.0%)
$37.60 M(-6.5%)
Sept 1997
-
$40.20 M(+12.0%)
June 1997
-
$35.90 M(+5.0%)
Mar 1997
-
$34.20 M(+3.6%)
Dec 1996
$28.90 M(+33.8%)
$33.00 M(+4.1%)
Sept 1996
-
$31.70 M(-0.6%)
June 1996
-
$31.90 M(+8.1%)
Mar 1996
-
$29.50 M(+5.7%)
Dec 1995
$21.60 M(+21.3%)
$27.90 M(+11.6%)
Dec 1994
$17.80 M(+10.6%)
$25.00 M(+41.2%)
Dec 1993
$16.10 M(+53.3%)
$17.70 M(+17.2%)
Dec 1992
$10.50 M(+128.3%)
$15.10 M(+0.7%)
Sept 1992
-
$15.00 M(+14.5%)
June 1992
-
$13.10 M(+4.0%)
Mar 1992
-
$12.60 M(+24.8%)
Dec 1991
$4.60 M(+9.5%)
$10.10 M(+13.5%)
Sept 1991
-
$8.90 M(+9.9%)
June 1991
-
$8.10 M(+6.6%)
Mar 1991
-
$7.60 M(+8.6%)
Dec 1990
$4.20 M(+5.0%)
$7.00 M(+32.1%)
Mar 1990
-
$5.30 M(-5.4%)
Dec 1989
$4.00 M(+25.0%)
$5.60 M(+19.1%)
Dec 1988
$3.20 M(+14.3%)
$4.70 M(+4.4%)
Dec 1987
$2.80 M
$4.50 M

FAQ

  • What is Taro Pharmaceutical Industries annual total current assets?
  • What is the all time high annual current assets for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual current assets year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly total current assets?
  • What is the all time high quarterly current assets for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly current assets year-on-year change?

What is Taro Pharmaceutical Industries annual total current assets?

The current annual current assets of TARO is $1.30 B

What is the all time high annual current assets for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual total current assets is $2.00 B

What is Taro Pharmaceutical Industries annual current assets year-on-year change?

Over the past year, TARO annual total current assets has changed by -$33.02 M (-2.47%)

What is Taro Pharmaceutical Industries quarterly total current assets?

The current quarterly current assets of TARO is $1.30 B

What is the all time high quarterly current assets for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly total current assets is $2.00 B

What is Taro Pharmaceutical Industries quarterly current assets year-on-year change?

Over the past year, TARO quarterly total current assets has changed by -$44.00 M (-3.27%)